Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
| NCT ID | NCT04393298 |
| Title | A Study to Assess the Safety, Pharmacokinetics and Antitumor Activity of UCB6114 Administered Intravenously to Participants With Advanced Solid Tumors |
| Recruitment | Active, not recruiting |
| Gender | both |
| Phase | Phase Ib/II |
| Variant Requirements | No |
| Sponsors | UCB Biopharma SRL |
| Indications | |
| Therapies | |
| Age Groups: | senior | adult |
| Covered Countries | USA | GBR |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Onc001 50414 | Los Angeles | California | 90033 | United States | Details | |
| Onc001 50470 | Charleston | South Carolina | 29425 | United States | Details | |
| Onc001 50471 | Houston | Texas | 77030 | United States | Details | |
| Onc001 40305 | Glasgow | United Kingdom | Details | |||
| Onc001 40113 | London | United Kingdom | Details | |||
| Onc001 40304 | Manchester | United Kingdom | Details | |||
| Onc001 40306 | Newcastle Upon Tyne | United Kingdom | Details | |||
| Onc001 40303 | Oxford | United Kingdom | Details | |||
| Onc001 40302 | Sutton | United Kingdom | Details |